Therapy development updates
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
Search
Search results
‘Talking’ Tech Peer Support Group
Thursday 20 November 2025, 7.00pm - 8.00pm - via Zoom - Come and join us for our latest meeting where we will be sharing some useful tech that was showcased at this years London Sight Village being held at the ILEC Conference Centre.
Hope To Seaview 2024
Join Colin & Linda McArthur for their annual Isle of Wight walk in support of Retina UK. Last year's event raised a record-breaking £6,000+!
Meet a researcher: Chloe Brotherton
As part of our aim to nurture young scientists, we are very pleased to introduce one of our new PhD students as part of a co-funding agreement with the Macular Society.
Research news round-up – Spring 2024
A round-up of the latest research into inherited retinal conditions - February 2024.
CRISPR Gene Editing Leads to Improvements
CRISPR gene editing leads to improvements in vision for people with inherited blindness, clinical trial shows.
Gene therapy treatment Luxturna accepted for use in Scotland
Retina UK is delighted that the Scottish Medicines Consortium (SMC) has accepted the gene therapy Luxturna (voretigene neparvovec) for ongoing use by the NHS in Scotland.
You could win £25,000 every week with the Retina UK Lottery!
Join the Retina UK Lottery for a weekly dose of good fortune and good deeds!
A new approach to treating inherited sight loss
A new approach to treating inherited sight loss
Webinar: The Big Give: How your donations make a difference
Join us to find out how your donations make a direct different and fund research.